Navigation Links
Contract Pharma Hosts 13th Annual Contracting & Outsourcing Conference
Date:8/6/2014

RAMSEY, N.J., Aug. 6, 2014 /PRNewswire/ -- Contract Pharma Magazine will host the 13th annual Contracting & Outsourcing Conference & Exhibition on Sept. 18-19, 2014 at the Hyatt Regency in New Brunswick, NJ. The event will feature speakers from FDA, large and small pharma and biopharma, and industry experts, with discussion of critical issues in outsourcing, including the Pfizer Keynote on Global Pharma Outsourcing Industry Trends and the Executive Outsourcing Summit.

Contracting & Outsourcing also features a one-day tabletop exhibition on Sept. 18, with 160 exhibitors from across the pharma and biopharma contract services spectrum. In addition, an end-of-day Networking Reception sponsored by Catalent Pharma Solutions enables attendees and exhibitors to mix and mingle outside of the exhibit hall.

Conference speakers include:

  • Sunil S. Ghogre, Senior Director/Team Lead – Operational Excellence,
    External Supply – Operating Unit, Pfizer Global Supply
  • FDA Keynote: tbd, CDER/FDA
  • Jim Miller, president, PharmSource
  • Kevin Siver, Ph.D., Senior Director, Quality Operations, Onyx
  • Mary Jo Lamberti, Ph.D., Senior Research Fellow, Tufts Center for the Study of Drug Development
  • Inigo Pfeiffer, Ph.D., Senior Staff Scientist, Pharmaceutical Development Group, Targacept, Inc.
  • Mark M. Yacura, shareholder at Buchanan Ingersoll & Rooney

"Contracting & Outsourcing continues to be among the most popular and admired conferences for pharmaceutical outsourcing services in the industry today," said Kristin Brooks, Associate Editor, Contract Pharma. "The ideal environment promotes friendly and casual discussions among sponsors and contract service providers throughout the event. Additionally, the conference sessions offer attendees valuable insight into the latest industry topics on best practices and regulatory trends, with speakers representing Pfizer, Amgen, Targacept, Tufts, and FDA, and more."     

The $395 attendee fee covers all conference sessions, the exhibit hall, the reception, and in-show meals and refreshment breaks. Prize giveaways at the end of day 1 are open to all attendees.

Contract Pharma's Contracting & Outsourcing Conference & Tabletop Exhibition is the industry's premier pharma and biopharma outsourcing event, annually drawing 400 decision-making attendees and 160 contract service providers for the conference and exhibition. Visit conference.contractpharma.com for more information, including a list of exhibitors, speaker bios, and event schedule.

Contract Pharma is the leading magazine covering the market for pharma and biopharma contract services and outsourcing. Celebrating its 15th anniversary in 2014, Contract Pharma has 20,000 subscribers worldwide, while its online presence, contractpharma.com, has 38,500 monthly visitors.

Media Contact: Kristin Brooks, Contract Pharma, 201-880-2226, kbrooks@rodmanmedia.com


'/>"/>
SOURCE Contract Pharma
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Wyle Wins NASAs Fully Integrated Lifecycle Mission Support Services Contract
2. U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract
3. ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
4. National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS
5. Pfenex Awarded Contract For Development Of Next Generation rPA-Based Anthrax Vaccine
6. CNTS Awarded $40 Million Contract Supporting U.S. Military Through Global Public Health
7. ITRA Global’s Detroit Affiliate Awarded Contract to Manage Real Estate for Michigan’s Western and Southeastern Regions
8. New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019
9. National Institute on Drug Abuse Awards SRI International Contract to Test Safety of Medications for Treatment of Substance Abuse
10. BioProcessing Solutions Alliance Wins Million Veteran Program Genotyping Contract
11. Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of its Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... According to a report by Transparency Market Research (TMR), ... the presence of a large pool of participants; however, only a ... Sigma-Aldrich, compete with each other in this market. With Proliant being ... of this market in 2016.  ... As of now, a large number of vendors are ...
(Date:3/23/2017)... , March 23, 2017 ... at four equities in the Biotech industry: Sangamo Therapeutics ... Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. ... st , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology ... downloading their free report at: ...
(Date:3/22/2017)... 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced ... U.K. Biobank and GSK to generate genetic sequence data from ... initiative will enable researchers to gain valuable insights to support ... range of serious and life threatening diseases. ... Genetic evidence has ...
(Date:3/22/2017)... 2017  Ascendis Pharma A/S (Nasdaq: ASND), a ... to address significant unmet medical needs in rare ... year ended December 31, 2016. ... as we broadened our pipeline and pursued our ... company with an initial focus on endocrinology," said ...
Breaking Biology Technology:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
Breaking Biology News(10 mins):